Mitt Romney, previous Republican Presidential Employee, had come forward to announce the success of his prostate surgery, which was done to remove a tumor and take care of cancer that he was diagnosed with. Romney got diagnosed with cancer earlier last year and recently underwent surgery after a rigorous course of treatments. Romney released a statement about his condition with the view of informing his supporters, in light of him standing once again for the selection which is soon approaching.
Romney underwent surgery at the hands of Dr. Ahlering, an oncological surgeon at Irvine Hospital. Situated in the state of California, Dr. Ahlering has performed surgery on countless other patients who have had similar conditions, and who wanted to seek the best for their treatment.
The number of people who are diagnosed with this kind of cancer is slowly on the rise. There can be mainly causational factors towards the emergence of disease, but the key is to provide the course of timely medications and treatment to the patients who have received a prostate cancer diagnoses.
The statistics of people who have a higher likelihood to get this form of cancer shed light on the demographics of people who should be wary. Six in ten people are likely to be diagnosed with some form of cancer, and most of this happens when the man has surpassed the age of sixty-five. There are incredibly few cases in which a man gets prostate cancer before the age of forty, though it isn’t entirely impossible. Romney fit the demographic of people likely to get prostate cancer quite well since he is about to turn seventy in the second week of March.
Romney isn’t the only politician coming forward to talk about their battle with cancer. In the past, several other candidates have also received a diagnosis of prostate cancer. Colin Powell and John Kerry are some of the few notable figures who in the past were diagnosed with this kind of cancer and had to seek treatment in the form of surgery.
Dr. David Samadi, an incredibly well-known doctor, came forward to shed light on the condition that Romney was in. According to him, Romney resodded incredibly well to the surgery and treatment and is already on his way to a speedy recovery who are receiving treatment under some of the best doctors in the entire country.
Many hear the name Eric Lefkofsky and think entrepreneurial kingpin. By co-founding companies like Groupon, Echo Global Logistics, and Uptake Technologies, he created a foundation of success in the world of tech startup companies. Now worth $1.7 billion according to Forbes, it may seem like he’s exited the world of company building and entered a life led by less involved endeavors.
Eric Lefkofsky statement would have been true, but then his wife Liz was diagnosed with breast cancer. A tumultuous time under the best of circumstances, Eric and Liz were baffled by the lack of comprehensive data to help develop treatments plans best suited for individual patients. Soon after Liz’s diagnosis, Lefkofsky took his degree from the University of Michigan and doctoral degree from the University of Michigan Law School and started one last company, Tempus.
Tempus still holds true to the nature of many of Lefkofsky’s other companies in that it is a data driven tech company. However, it isn’t geared towards local commerce or marketing. The goal of Tempus is to create a wheelhouse of data from doctors from some of the nation’s leading medical institutions. The startup established connections with the Mayo Clinic, the University of Chicago, Northwestern University, and the University of Michigan. Oncologists at these facilities send their patients to Tempus where they are then sequenced in Tempus’ lab. This data is stored and then each patient is paired up with cancer clinical information that matched their molecular profile. This comprehensive data is then sent back to the attending oncologist so that they can utilize whatever methods are most ideal for any individual nuances of that patient’s pathology to learn more: https://www.insidephilanthropy.com/guide-to-individual-donors/eric-lefkofsky.html click here.
This chain of events may seem like Tempus is a medical company, however, at the end of the day, it is still a tech company. It is merely driven by medical data in order to create a hub for cancer treatment methods and access. The impact for a company like Tempus will take years to see fully fulfilled. However, when those results reveal themselves, the impact will likely be life saving for millions.
Clay Siegall is one of the most active researchers regarding cancer. He has personally involved himself in decades of research examining cancer and how patients respond to various treatments. This research he did in the 90s eventually led him to the creation of Seattle Genetics. At Seattle Genetics, Clay Siegall has patented various products and brought them to market. Seattle Genetics is so successful Siegall is now talking to various pharmaceutical companies such as Pfizer which are interested in bring his products into the market.
The Magic At Work At Seattle Genetics
The major accomplishment of Clay Siegall at Seattle Genetics is the antibody-drug conjugate. This unique treatment option fights cancer by using antibodies to deliver drugs in an attempt to prevent the body from regarding the drugs as foreign to the body. The treatment method offers an advantage because it prevents many of the side effects often observed in cancer therapy. Cancer therapy as it stands today is woefully unprepared to help the patients in need of it. They may experience hair loss, organ failure, and other undesirable side effects on their road to recovery. These breakthroughs are a step in the right direction to eliminate that altogether.
Where It All Goes From Here
Seattle Genetics was able to generate more than $500 million in revenue from investors the last time the firm decided to seek out investors. Clearly, there is a strong interest in Seattle Genetics and there are clearly many interested in the firm’s potential. Clay Siegall has already given the world an amazing breakthrough in oncology, but he is far from finished with his studies. He wants to do so much more with his work.
About Clay Siegall
Clay Siegall is a cancer researcher with a strong focus on finding safer ways to treat cancer. He has worked with various institutions over the course of the years in order to better understand how cancer develops and how to treat it. He has used this research to create Seattle Genetics and the center’s key breakthroughs.